MétaCan
Menu
Back to cohort
Record W4399299590 · doi:10.1186/s12885-023-11425-w

Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition

2024· article· en· W4399299590 on OpenAlexaff
Tuck Seng Cheng, Urwah Noor, Eleanor L. Watts, Michaël Pollak, Ye Wang, James McKay, Joshua Atkins, Giovanna Masala, María‐José Sánchez, Antonio Agudo, Jesús Castilla, Dagfinn Aune, Sandra M. Colorado‐Yohar, Luca Manfredi, Marc J. Gunter, Valeria Pala, Andreas Josefsson, Timothy J. Key, Karl Smith-Byrne, Ruth C. Travis

Bibliographic record

VenueBMC Cancer · 2024
Typearticle
Languageen
FieldMedicine
TopicGrowth Hormone and Insulin-like Growth Factors
Canadian institutionsMcGill UniversityJewish General Hospital
FundersNational Cancer InstituteSchool of Public Health, Imperial College LondonNIHR Imperial Biomedical Research CentreInstituto de Salud Carlos IIIRijksinstituut voor Volksgezondheid en MilieuWorld Cancer Research FundMedical Research CouncilNational Institutes of HealthInstitut Gustave-RoussyDeutsche KrebshilfeInstitut National de la Santé et de la Recherche MédicaleMutuelle Générale de l'Education NationaleImperial College LondonAssociazione Italiana per la Ricerca sul CancroCancerfondenBundesministerium für Bildung und ForschungLigue Contre le CancerNational Institute for Health and Care ResearchVetenskapsrådetCancer Research UKDeutsches KrebsforschungszentrumWorld Health Organization
KeywordsProstate cancerMedicineCancerInternal medicineProspective cohort studyNested case-control studyOncologyProstateInterquartile rangeRisk factorInsulin-like growth factorOdds ratioEuropean Prospective Investigation into Cancer and NutritionSurgical oncologyGrowth factor

Abstract

fetched live from OpenAlex

BACKGROUND: Circulating total insulin-like growth factor-I (IGF-I) is an established risk factor for prostate cancer. However, only a small proportion of circulating IGF-I is free or readily dissociable from IGF-binding proteins (its bioavailable form), and few studies have investigated the association of circulating free IGF-I with prostate cancer risk. METHODS: We analyzed data from 767 prostate cancer cases and 767 matched controls nested within the European Prospective Investigation into Cancer and Nutrition cohort, with an average of 14-years (interquartile range = 2.9) follow-up. Matching variables were study center, length of follow-up, age, and time of day and fasting duration at blood collection. Circulating free IGF-I concentration was measured in serum samples collected at recruitment visit (mean age 55 years old; standard deviation = 7.1) using an enzyme-linked immunosorbent assay (ELISA). Conditional logistic regressions were performed to examine the associations of free IGF-I with risk of prostate cancer overall and subdivided by time to diagnosis (≤ 14 and > 14 years), and tumor characteristics. RESULTS: Circulating free IGF-I concentrations (in fourths and as a continuous variable) were not associated with prostate cancer risk overall (odds ratio [OR] = 1.00 per 0.1 nmol/L increment, 95% CI: 0.99, 1.02) or by time to diagnosis, or with prostate cancer subtypes, including tumor stage and histological grade. CONCLUSIONS: Estimated circulating free IGF-I was not associated with prostate cancer risk. Further research may consider other assay methods that estimate bioavailable IGF-I to provide more insight into the well-substantiated association between circulating total IGF-I and subsequent prostate cancer risk.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.046
Threshold uncertainty score0.989

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.280
Teacher spread0.258 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueBMC CancerSame topicGrowth Hormone and Insulin-like Growth FactorsFrench-language works237,207